Funding opportunities
172 live opportunities from Grants.gov, NIH, NSF, and more.
Energy & Sustainability× remove
- Targeting Mitochondrial Fusion in Colorectal CancerNational Cancer InstitutePAR-24-117 closes 5/31/2029up to $190,944activenih
- Kinase-Focused Target Identification and Structure Activity Relationship Exploration for a Novel Angelman Syndrome Therapeutic.National Institute of Neurological Disorders and StrokePA-25-422 closes 5/31/2029up to $41,404activenih
- Muscle metabolism, metabolic modulators and disabling exercise intolerance in the daily life of patients with heart failure and preserved ejection fractionNational Heart Lung and Blood InstitutePA-20-188 closes 4/30/2029up to $248,919activenih
- Effect of Cyp2e1 Deletion on Methylglyoxal Detoxification Through the Nrf2 PathwayNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-422 closes 6/15/2028up to $50,114activenih
- Impact of environmental toxicants on frontal cortical circuitsNational Institute of Environmental Health SciencesPA-25-304 closes 6/10/2028up to $394,165activenih
- Unraveling the impact of NUP98-HOXA9 on DNA damage responsesNational Institute of Environmental Health SciencesPA-25-304 closes 6/8/2028up to $452,547activenih
- The role of constitutive interferon-kappa production in antiviral defense in human skinNational Institute of Allergy and Infectious DiseasesPA-23-271 closes 6/3/2028up to $35,446activenih
- Perfusion CT for liver radioembolizationNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $409,141activenih
- Beyond blocking virus entry: Role of SERINC5 as a shield of genomic integrityNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $407,091activenih
- Harnessing antibody-driven bioconjugation to modulate immune functionNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $182,196activenih
- Regulation of HIV-1 fusion competence by spacer peptide 2 and matrix proteinNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $430,375activenih
- Combined pharmacologic and AAV gene therapy of pyruvate dehydrogenase deficiencyEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-304 closes 5/31/2028up to $419,375activenih
- Deciphering the overlapping and unique roles of three RNA-binding proteins during oocyte meiosis and early embryogenesisEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-304 closes 5/31/2028up to $450,250activenih
- Overcoming Treatment Resistance by Targeting Polyploid Breast Cancer Cells with AI assisted Single-Cell AnalysisNational Cancer InstitutePAR-25-346 closes 5/31/2028up to $408,829activenih
- Ketogenic Approach to Restore Muscle in older patients with community-Acquired Pneumonia - KARMA-P TrialNational Institute on AgingPA-25-306 closes 5/31/2028up to $409,750activenih
- Quantitative Predictive Dosimetry for Curative Transarterial RadioembolizationNational Cancer InstitutePAR-25-135 closes 5/31/2028up to $161,460activenih
- Disparities in AML treatmentNational Cancer InstitutePAR-25-244 closes 5/31/2028up to $422,649activenih
- EBV Modulation of Genome Stability in B-cell LymphomaNational Cancer InstitutePAR-25-135 closes 5/31/2028up to $117,144activenih
- Combining CRISPR-Cas9 base editing and proteomics to determine how filovirus VP24 proteins modulate ubiquitination and viral replicationNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $462,000activenih
- The impact of chronic low dose cadmium exposure on skeletal growth and maintenance in mice modelsEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-302 closes 5/31/2028up to $156,500activenih
- Antisense Oligonucleotide-Based Therapeutic Strategy for Genetic Obesity Caused by MC4R MutationsEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-304 closes 5/31/2028up to $423,500activenih
- Identification of transcription factors that promote pulmonary infectionNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $452,375activenih
- Characterizing adipocyte heterogeneity in response to metabolic stressNational Institute of Diabetes and Digestive and Kidney DiseasesPAR-25-091 closes 5/31/2028up to $123,000activenih
- Targeted Prodrug Cytokines for Metastatic Breast Cancer ImmunotherapyNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $384,524activenih
- Role of the Rev-Rev Response Element Regulatory Axis in HIV TransmissionNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $282,625activenih